Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on February 3, 2026

Feb. 3, 2026

Free YMCA diabetes program to help people lower risk and stay healthy is expanding across Edmonton

GlobeNewswire

Feb. 3, 2026

Ballad Health welcomes Mike Anderes as managing director of Ballad Ventures

GlobeNewswire

Feb. 3, 2026

NCPA Cheers as Trump Signs First Major PBM Reform in Decades

GlobeNewswire

Feb. 3, 2026

NASP Applauds Congressional Passage of Landmark Bill to Protect Patient Access to Specialty Pharmacies and Support Specialty Pharmacy Businesses

GlobeNewswire

Feb. 3, 2026

Banner Health taps finance leader for strategy and growth role

GlobeNewswire

Feb. 3, 2026

Telix Full Year Results 2025 Investor Webcast Notification

GlobeNewswire

Feb. 3, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 3, 2026

BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026

GlobeNewswire

Feb. 3, 2026

Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement

GlobeNewswire

Feb. 3, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 3, 2026

InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025

GlobeNewswire

Feb. 3, 2026

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference

GlobeNewswire

Feb. 3, 2026

BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research

GlobeNewswire

Feb. 3, 2026

Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026

GlobeNewswire

Feb. 3, 2026

Bipartisan Congressional Action Advances Critical Programs for Rare Neuromuscular Disease Research and Care

GlobeNewswire

Feb. 3, 2026

Berry Street Named to 2026 New York Digital Health 100 List

GlobeNewswire

Feb. 3, 2026

Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

GlobeNewswire

Feb. 3, 2026

RESTEM Announces First Patient Dosed in the Phase 2/3 IIMPACT Study of Restem-L in Idiopathic Inflammatory Myopathy

GlobeNewswire

Feb. 3, 2026

Socrates Health Solutions Announces Advances in Proprietary Non-Invasive Glucose Monitoring Technology; Shareholders Include NFL Players Association and OneTeam Partners

GlobeNewswire

Feb. 3, 2026

Adam Ferrari Announces 2026 Health Science Scholarship to Support Students Dedicated to Caring for Patients with Physical Disabilities

GlobeNewswire